Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] - N0000194015

Pharmacologic Code	N0000194015
Pharmacologic Name	Glucose-dependent Insulinotropic Polypeptide Receptor Agonist
Pharmacologic Uses	glucose-dependent insulinotropic polypeptide (GIP) receptor agonist
Pharmacologic Concept	Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description	An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions: A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication. A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

The table contains 24 products whose active ingredient are classified under the same pharmacologic class Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	0002-0152	Zepbound	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
	0002-0243	Zepbound	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
	0002-1152	Mounjaro	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
	0002-1214	Zepbound	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
	0002-1243	Mounjaro	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
	0002-1340	Zepbound	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
	0002-1423	Zepbound	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
	0002-1457	Mounjaro	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
	0002-1460	Mounjaro	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
	0002-1471	Mounjaro	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
	0002-1484	Mounjaro	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
	0002-1495	Mounjaro	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
	0002-1506	Mounjaro	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
	0002-2002	Zepbound	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
	0002-2214	Mounjaro	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
	0002-2340	Mounjaro	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
	0002-2423	Mounjaro	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
	0002-2457	Zepbound	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
	0002-2460	Zepbound	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
	0002-2471	Zepbound	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
	0002-2484	Zepbound	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
	0002-2495	Zepbound	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
	0002-2506	Zepbound	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
	0002-3002	Mounjaro	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE